|
danger
of Bextra or Valdecoxib include the following:
-
Potential
for increased risk of cardiovascular events
-
Gastrointestinal
bleeding
-
Serious
skin reactions, some resulting in death.
If
you are currently on Bextra check with your doctor, especially
if you have a history of heart problems.
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the market "because the overall
risk versus benefit profile for the drug is unfavorable."
FDA
INFORMATION
The
FDA's announcement withdrawing
Bextra.
To
report any unexpected adverse or serious events associated
with the use of Bextra® contact the FDA MedWatch program
on the internet or at 1-800-FDA-1088
What
is Bextra?
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
bextra
site map
Autism
Education Materials!
|
